BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
44.165 EUR
+1.48 (+3.47%)
Taking everything into account, BAYN scores 2 out of 10 in our fundamental rating. BAYN was compared to 54 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of BAYN have multiple concerns. BAYN has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year BAYN was profitable.
- BAYN had a positive operating cash flow in the past year.
- In multiple years BAYN reported negative net income over the last 5 years.
- BAYN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -0.19%, BAYN is doing worse than 66.67% of the companies in the same industry.
- The Return On Equity of BAYN (-0.67%) is worse than 66.67% of its industry peers.
- BAYN's Return On Invested Capital of 1.80% is on the low side compared to the rest of the industry. BAYN is outperformed by 66.67% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for BAYN is significantly below the industry average of 13.93%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROIC | 1.8% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
1.3 Margins
- With a Operating Margin value of 4.20%, BAYN is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
- In the last couple of years the Operating Margin of BAYN has declined.
- BAYN's Gross Margin of 56.35% is on the low side compared to the rest of the industry. BAYN is outperformed by 68.52% of its industry peers.
- In the last couple of years the Gross Margin of BAYN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
- BAYN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- BAYN has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for BAYN remains at a similar level compared to 5 years ago.
- The debt/assets ratio for BAYN has been reduced compared to a year ago.
2.2 Solvency
- BAYN has an Altman-Z score of 1.00. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of 1.00, BAYN is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
- The Debt to FCF ratio of BAYN is 10.07, which is on the high side as it means it would take BAYN, 10.07 years of fcf income to pay off all of its debts.
- With a Debt to FCF ratio value of 10.07, BAYN is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
- BAYN has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.11, BAYN is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 1 |
ROIC/WACC0.27
WACC6.59%
2.3 Liquidity
- A Current Ratio of 1.14 indicates that BAYN should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.14, BAYN is doing worse than 64.81% of the companies in the same industry.
- BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
- BAYN's Quick ratio of 0.71 is on the low side compared to the rest of the industry. BAYN is outperformed by 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
- BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
- BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
- Looking at the last year, BAYN shows a decrease in Revenue. The Revenue has decreased by -1.87% in the last year.
- BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
- Based on estimates for the next years, BAYN will show a small growth in Earnings Per Share. The EPS will grow by 3.51% on average per year.
- The Revenue is expected to grow by 1.22% on average over the next years.
EPS Next Y-5.16%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
EPS Next 5Y3.51%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- BAYN is valuated reasonably with a Price/Earnings ratio of 8.27.
- BAYN's Price/Earnings ratio is rather cheap when compared to the industry. BAYN is cheaper than 98.15% of the companies in the same industry.
- When comparing the Price/Earnings ratio of BAYN to the average of the S&P500 Index (27.32), we can say BAYN is valued rather cheaply.
- The Price/Forward Earnings ratio is 9.07, which indicates a very decent valuation of BAYN.
- Based on the Price/Forward Earnings ratio, BAYN is valued cheaper than 92.59% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of BAYN to the average of the S&P500 Index (24.32), we can say BAYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.27 | ||
| Fwd PE | 9.07 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BAYN is valued a bit cheaper than 61.11% of the companies in the same industry.
- 88.89% of the companies in the same industry are more expensive than BAYN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.03 | ||
| EV/EBITDA | 11.88 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.26%, BAYN is not a good candidate for dividend investing.
- BAYN's Dividend Yield is slightly below the industry average, which is at 1.59.
- Compared to an average S&P500 Dividend Yield of 1.83, BAYN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.26% |
5.2 History
- The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-65.15%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
FRA:BAYN (1/22/2026, 5:36:15 PM)
44.165
+1.48 (+3.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners49.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap43.39B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts74.29
Price Target35.11 (-20.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.26% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)7.75%
PT rev (3m)20.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.17%
EPS NY rev (1m)0.49%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.27 | ||
| Fwd PE | 9.07 | ||
| P/S | 0.95 | ||
| P/FCF | 11.03 | ||
| P/OCF | 6.45 | ||
| P/B | 1.47 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.88 |
EPS(TTM)5.34
EY12.09%
EPS(NY)4.87
Fwd EY11.02%
FCF(TTM)4.01
FCFY9.07%
OCF(TTM)6.84
OCFY15.49%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROCE | 2.56% | ||
| ROIC | 1.8% | ||
| ROICexc | 2% | ||
| ROICexgc | 6.8% | ||
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM | 8.58% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 5.32 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 1.09 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 1 |
F-Score5
WACC6.59%
ROIC/WACC0.27
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.16%
EPS Next 2Y-1.81%
EPS Next 3Y1.63%
EPS Next 5Y3.51%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.28%
EBIT Next 3Y21.41%
EBIT Next 5Y12.99%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 2 / 10 to BAYN.DE.
What is the valuation status of BAYER AG-REG (BAYN.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Fairly Valued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
How financially healthy is BAYER AG-REG?
The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.
How sustainable is the dividend of BAYER AG-REG (BAYN.DE) stock?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.